Njbio India Pharmaceutical Private Limited, a active private limited company, was established on 10 January 2019 in Mumbai, Maharashtra, India. Engaging in consumer professional services within the professional, scientific and technical sector, it holds CIN: U73100MH2019PTC319319. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹16.37 Cr.
Formerly known as Amar Chemistry Private Limited. It upholds a compliant status. Employing 38 professional, Its leadership includes Arpit Pokharna (Director), Rahul Suresh Bagul (Whole-Time Director), Nareshkumar Fulchand Jain (Director). Past directors included Arpit Pokharna, Arpit Pokharna, Vishal Naresh Shah. It holds no open charges and ₹8.16 Cr settled loans. Its latest AGM occurred on 22 August 2025, with the balance sheet filed on 31 March 2025. It is based at G-1, G-1A, Ground Floor, Ackruti Corporate Park, Cts No 586,586/1,Lbs Marg,Kanjur Village, ,Bhandup W, Mumbai, Maharashtra, 400078.
U73100MH2019PTC319319
319319
10 January 2019
₹20.00 Cr
₹16.37 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Njbio India Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arpit Pokharna | Director | 01 Sep 2023 | Current |
| Rahul Suresh Bagul | Whole-Time Director | 16 Dec 2024 | Current |
| Nareshkumar Fulchand Jain | Director | 10 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2023 | Past |
| Pramod Abcsdd | Cfo | - | Past |
| Pramod Abcsdd | Managing Director | 01 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 23 Apr 2025 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Njbio India Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 114.92% increase. The company also saw a substantial improvement in profitability, with a 235.45% increase in profit. The company's net worth Soared by an impressive increase of 258.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Njbio India Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹81,615,600.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Aug 2019 | Hdfc Bank Limited | ₹8.16 Cr | Satisfied |
Explore comprehensive loan charge details -
Njbio India Pharmaceutical has a workforce of 38 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Njbio India Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Njbio India Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Tanveer Fatima was appointed as a Company Secretary was appointed as a Company Secretary on 12 Sep 2025 & has been associated with this company since 2 months 19 days . was completed.
Progress on Njbio India Pharmaceutical Private Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records. was documented.
Progress on Swati Mathur was appointed as a Cfo was appointed as a Cfo on 03 Jul 2025 & has been associated with this company since 4 months 29 days . was documented.
The activity Njbio India Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Progress on Rahul Suresh Bagul was appointed as a Whole-time director was appointed as a Whole-time director on 16 Dec 2024 & has been associated with this company since 11 months 14 days . was documented.
The activity Arpit Pokharna was appointed as a Director was appointed as a Director on 01 Sep 2023 & has been associated with this company since 2 years 3 months . was completed.
The CIN of Njbio India Pharmaceutical Private Limited is U73100MH2019PTC319319.
Njbio India Pharmaceutical Private Limited is headquartered at G-1, G-1A, Ground Floor, Ackruti Corporate Park, Cts No 586,586/1,Lbs Marg,Kanjur Village, ,Bhandup W, Mumbai, Maharashtra, 400078.
Njbio India Pharmaceutical Private Limited was incorporated on 10 January 2019.
The current directors of Njbio India Pharmaceutical Private Limited are
The primary industry of Njbio India Pharmaceutical Private Limited is Professional, Scientific And Technical.
Njbio India Pharmaceutical Private Limited is unlisted.
The authorized capital of Njbio India Pharmaceutical Private Limited is ₹20.00 Cr, and the paid-up capital is ₹16.37 Cr.
The compliance status of Njbio India Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX